Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Amgen, Inc AstraZeneca; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc; Bristol Myers Squibb; Daiichi Sankyo, Inc; Jazz Pharmaceuticals, Novartis Pharmaceuticals Corporation, Pfizer Inc, and Takeda Oncology.

Community Practice Connections™: 21st Annual International Lung Cancer Congress®

Release Date: October 30, 2020
Expiration Date: October 30, 2021

Activity Overview

Community Practice Connections™: 21st Annual International Lung Cancer Congress® consists of a series of interactive clinical vignettes, short video interviews of leading experts in lung cancer, and short summaries of clinical data related to these issues. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Amgen, Inc AstraZeneca; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc; Bristol Myers Squibb; Daiichi Sankyo, Inc; Jazz Pharmaceuticals, Novartis Pharmaceuticals Corporation, Pfizer Inc, and Takeda Oncology.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify biomarkers and testing strategies to optimize selection of therapy in patients with lung cancer
  • Evaluate emerging evidence concerning the management of patients with non-metastatic lung cancer
  • Apply recent data sets on single-agent and combination immunotherapeutic approaches to care for patients with advanced thoracic malignancies
  • Assess recent clinical data on targeted and cytotoxic strategies for the management of patients with thoracic malignancies
  • Discuss optimal and personalized sequencing strategies utilizing clinical trial evidence, performance status, and tumor characteristics
  • Describe the current status of current clinical trials or approaches to address variances in care for patients with thoracic malignancies

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

David R. Gandara, MD
David R. Gandara, MD
Professor of Medicine Emeritus
Division of Hematology/Oncology
Director of Thoracic Oncology
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA

Disclosures: Grant Research Support: Bristol Myers Squibb, Merck and Company, Novartis, Roche-Genentech; Consultant: AstraZeneca, Celgene, CellMax Life, Eli Lilly and Company, FujiFilm, Guardant Health, Inivata Limited, IO Biotech, Liquid Genomics, Merck and Company, Samsung Bioepis, Pfizer, Roche-Genentech.

Roy S. Herbst, MD, PhD
Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
Yale School of Medicine
New Haven, CT

Disclosures: Grant Research Support: AstraZeneca, Eli Lilly and Company, Genentech/Roche, Merck and Company; Consultant: AbbVie Pharmaceuticals, ARMO Biosciences, AstraZeneca, Biodesix, Bolt Biotherapeutics, Bristol Myers Squibb, Cybrexa, Genentech/Roche, Genmab, Halozyme, Heat Biologics, IMAB Biopharma, Immunocore, Infinity Pharmaceuticals, Loxo Oncology, Merck and Company, Mirati Therapeutics, Nektar, Neon Therapeutics, NextCure, Novartis, Pfizer, Sanofi, Seattle Genetics, Shire PLC, Spectrum Pharmaceuticals, Symphogen, Takeda Pharmaceutical Company, Tesaro, Tocagen, WindMIL Therapeutics.

Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Leslye M. Heisler Assistant Professor for Lung Cancer Excellence
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

Disclosures: Grant Research Support: AstraZeneca, MacroGenics, Merck and Company; Consultant: AstraZeneca, Bristol Myers Squibb, Celgene, Eli Lilly and Company, Genentech.

Benjamin P. Levy, MD
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC

Disclosures: Consultant: AstraZeneca, Celgene, Eli Lilly and Company, Genentech, Merck ad Company, Takeda Pharmaceutical Company.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
2930
Filter By